Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Kopinski, G. Przybylski, J. Chorostowska-Wynimko, A. Dyczek, K. Szablowska, E. Pólgesek, J. Golinska (Bydgoszcz, Warszawa, Krakow, Poland). Increased apoptosis of alveolar lymphocytes (AL) in idiopathic pulmonary fibrosis (IPF). Potential mechanisms and practical considerations. Eur Respir J 2013; 42: Suppl. 57, 3383

Member's Comments

No comment yet.

Related content which might interest you: Studies on hepatocyte growth factor (HGF) in bronchoalveolar lavage (BAL) do not support the concept on its antifibrotic properties in idiopathic pulmonary fibrosis (IPF) Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 Changes of BAL findings as no progression marker in idiopathic pulmonary fibrosis (IPF) patients treated with IFN-g Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases Year: 2006 Autophagy is not impaired in BALF alveolar macrophages in IPF: Preliminary results Source: International Congress 2014 – ILDs 3 Year: 2014 Effect of low level laser therapy in a model of pulmonary idiopathic fibrosis Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 Cytofluorimetric BAL cells characterization in IPF and in other ILD Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Galactomannans in bronchoalveolar lavage of patients with Idiopathic Pulmonary Fibrosis (IPF): a possible marker of disease progression. Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia Year: 2019 Pathogenetic pathways in pulmonary fibrosis: The role of bronchoalveolar lavage (BAL) cellularity in relation to epithelial injury Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease Year: 2010 Airway dendritic cell phenotypes in inflammatory diseases of the human lung Source: Eur Respir J 2007; 30: 878-886 Year: 2007 Alveolar lymphocytes (AL) apoptosis in interstitial lung diseases (ILD). Increased AL apoptosis rate in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis Year: 2009 The programmed death of alveolar lymphocytes is elevated in idiopathic pulmonary fibrosis (IPF). The plausible explanation of well-known bronchoalveolar lavage cytological findings? Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside Year: 2017 Screening potential biomarkers for idiopathic pulmonary fibrosis in bronchoalveolar lavage fluid Source: International Congress 2014 – ILDs 1 Year: 2014 Bronchoalveolar lavage Source: Eur Respir Mon; 2010: 48: 59–72 Year: 2010 Clinical and functional features in idiopathic pulmonary fibrosis (IPF) with and without haemosiderin-laden alveolar macrophages on BALF Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease Year: 2011 Transcriptome analysis in endobronchial epithelial lining fluid compared to bronchoalveolar lavage in idiopathic pulmonary fibrosis Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Analysis of cellular components of bronchoalveolar lavage fluid in idiopathic pulmonary fibrosis and pulmonary sarcoidosis: focus on lymphocyte and macrophage subpopulations Source: Annual Congress 2008 - Allergy and immunology of asthma and beyond Year: 2008 Cytokines, chemokines and growth factors concentration in BAL fluid from patients with Idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP) Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020 Biomarkers of fibroproliferative healing in fibrosing idiopathic interstitial pneumonias Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Enhanced apoptosis of alveolar lymphocytes (AL), but not macrophages (AM) in interstitial idiopathic pneumonias (IIPs). Special attention to idiopathic pulmonary fibrosis (IPF) results Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010 Analysis of inflammatory networks in interstitial lung disease in patients with rheumatoid arthritis Source: International Congress 2016 – Connective tissue disorders Year: 2016 CD163 positive alveolar macrophages from bronchoalveolar lavage in idiopathic pulmonary fibrosis and lung cancer. Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis Year: 2019